The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies (Q33682785)

28 July 2017

1 reference

title

The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies (English)

1 reference

28 July 2017

Thompson WD

1 reference

28 July 2017

Li WW

series ordinal

1 reference

28 July 2017

Maragoudakis M

series ordinal

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

187

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

503-510

1 reference

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Observations on the growth of blood vessels into the cornea; application of a new experimental technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Angiogenesis and angiogenesis inhibitors in paediatric diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Factors Controlling Ocular Angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Fibrin as a factor in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Coronary aneurysms after stent placement: a suggestion of altered vessel wall healing in the presence of anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Vascularization of the mouse embryo: A study of flk‐1, tek, tie, and vascular endothelial growth factor expression during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

New anti-angiogenesis agents: review of the clinical experience with carboxyamido-triazole (CAI), thalidomide, TNP-470 and interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Dual pathways of tubular morphogenesis of vascular endothelial cells by human glioma cells: vascular endothelial growth factor/basic fibroblast growth factor and interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

Role of tumor necrosis factor-α and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9896%28199904%29187%3A5%3C503%3A%3AAID-PATH279%3E3.0.CO%3B2-2

10.1002/(SICI)1096-9896(199904)187:5<503::AID-PATH279>3.0.CO;2-2

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference